Suppression of ferroportin expression by cadmium stimulates proliferation, EMT, and migration in triple-negative breast cancer cells.

Suppression of ferroportin expression by cadmium stimulates proliferation, EMT, and migration in triple-negative breast cancer cells.
复制标题

DOI:
10.1016/j.taap.2018.07.017
复制
发表时间:
2018-10-01
影响因子:
3.8
通讯作者:
Shaikh ZA
Shaikh ZA
中科院分区:
医学3区
文献类型:
--
作者:
Shan Z;Wei Z;Shaikh ZA

文献摘要

参考文献

被引文献

相似文献

镉(Cd)与多种癌症有关,包括乳腺癌;然而,其致癌活性的分子机制尚不完全清楚。为此,本研究调查了铁转运蛋白(FPN),乳腺癌的预后标志物,在cd诱导的细胞增殖和细胞迁移的刺激中的作用。三阴性MDA-MB-231细胞经1-3 μM Cd处理后,细胞中FPN表达显著降低,铁浓度随之升高。Cd处理8周后,细胞增殖和迁移活性升高,与FPN表达呈负相关。E-cadherin表达增加,N-cadherin、Twist和Slug表达减少,表明FPN表达减少也导致EMT。进一步的研究表明,Cd至少部分通过激活TGF-ß抑制FPN表达,TGF-ß是一种已知的FPN表达调节因子。综上所述,这些结果表明cd诱导的MDA-MB-231细胞增殖、EMT和迁移的刺激是通过抑制FPN表达和相关的铁稳态破坏来实现的。
Cadmium (Cd) has been linked to a variety of cancers, including breast cancer; however, the molecular mechanism of its carcinogenic activity is not fully understood. To this end, the present study investigated the roles of ferroportin (FPN), a prognostic marker of breast cancer, in Cd-induced stimulation of cell proliferation and cell migration. Triple-negative MDA-MB-231 cells were treated with 1–3 μM Cd. The cells exhibited significant reduction in FPN expression and concomitant increase in iron concentration. Cells treated with Cd for 8 weeks displayed elevated proliferative and migratory activities which were inversely related with FPN expression. Reduced FPN expression also resulted in EMT as indicated by an increase in the expression of E-cadherin, and a decrease in the expression of N-cadherin, Twist and Slug. Further investigation revealed that Cd suppressed FPN expression at least partially by activating TGF-ß, a known regulator of FPN expression. Taken together, these results indicate that Cd-induced stimulation of MDA-MB-231 cell proliferation, EMT, and migration is brought about by suppression of FPN expression and associated disruption of iron homeostasis.
DOI: 10.3390/ijms140816600
发表时间: 2013-08-12
影响因子: 5.6
作者:
Asara Y;Marchal JA;Carrasco E;Boulaiz H;Solinas G;Bandiera P;Garcia MA;Farace C;Montella A;Madeddu R
通讯作者: Madeddu R
DOI: 10.1038/cddis.2014.339
发表时间: 2014-08-14
影响因子: 9
作者:
通讯作者: --
DOI: 10.1038/oncsis.2016.17
发表时间: 2016-03-21
期刊: Oncogenesis
影响因子: 6.2
作者:
Bassey-Archibong BI;Kwiecien JM;Milosavljevic SB;Hallett RM;Rayner LG;Erb MJ;Crawford-Brown CJ;Stephenson KB;Bédard PA;Hassell JA;Daniel JM
通讯作者: Daniel JM
DOI: 10.1016/j.taap.2013.06.013
发表时间: 2013-12-01
影响因子: 3.8
作者:
Person RJ;Tokar EJ;Xu Y;Orihuela R;Ngalame NN;Waalkes MP
通讯作者: Waalkes MP
DOI: 10.1016/j.ebiom.2017.04.036
发表时间: 2017-06
期刊: EBioMedicine
影响因子: 11.1
作者:
Neves J;Leitz D;Kraut S;Brandenberger C;Agrawal R;Weissmann N;Mühlfeld C;Mall MA;Altamura S;Muckenthaler MU
通讯作者: Muckenthaler MU